Showing results (1-10 of 137) with videos related to
Sort By:
Pageof 14
Cell Host & Microbe|May 15, 2025
Antibiotics fire up inflammation to cool vaccine responsivenessJames G KublinCurrent HIV Research|September 17, 2013
Lessons learned from HIV vaccine clinical efficacy trialsTracey A Day, James G KublinClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2005
Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasisMelanie Walker, James G Kublin, Joseph R ZuntMalaria Journal|May 3, 2024
Statistical design and analysis of controlled human malaria infection trialsXiaowen Tian, Holly E Janes, James G KublinScience (New York, N.Y.)|December 13, 2006
Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan AfricaLaith J Abu-Raddad, Padmaja Patnaik, James G KublinCurrent Opinion in HIV and AIDS|September 26, 2023
Targeting enhanced neutralizing antibody responses via increased germinal center activity: early-phase vaccine trials with novel clinical designsWilliam O Hahn, Joshua A Hill, James G KublinCurrent Opinion in HIV and AIDS|November 28, 2017
Utilizing gnotobiotic models to inform the role of the microbiome in vaccine response heterogeneityJacob A Cram, Kevin W Hager, James G KublinArchives of Internal Medicine|September 26, 2007
Challenges in the prevention, diagnosis, and treatment of malaria in human immunodeficiency virus infected adults in sub-Saharan AfricaPaula E Brentlinger, Christopher B Behrens, James G KublinEbiomedicine|February 5, 2016
Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical ModelsDobromir Dimitrov, James G Kublin, Scott Ramsey, et al.Vaccines|May 25, 2017
The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United StatesBlythe J S Adamson, Josh J Carlson, James G Kublin, et al.Pageof 14